{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:46:05Z","timestamp":1788403565837,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,15]]},"DOI":"10.1097\/tp.0b013e3181b75374","type":"journal-article","created":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T03:15:01Z","timestamp":1254453301000},"page":"935-941","source":"Crossref","is-referenced-by-count":53,"title":["Proteinuria-Reducing Effects of Tonsillectomy Alone in IgA Nephropathy Recurring After Kidney Transplantation"],"prefix":"10.1097","volume":"88","author":[{"given":"Takafumi","family":"Kennoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210211","first-page":"147","article-title":"Tonsillectomy does not prevent a progressive course in IgA nephropathy.","volume":"51","author":"Rasche","year":"1999","journal-title":"Clin Nephrol"},{"key":"R2-14-20210211","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","article-title":"Corticosteroid effectiveness in IgA nephropathy. Long term results of a randomized, controlled trial.","volume":"15","author":"Pozzi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R3-14-20210211","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/ajkd.2001.27690","article-title":"Tonsillectomy and steroid pulse therapy significantly impact in patients with IgA nephropathy.","volume":"38","author":"Hotta","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R4-14-20210211","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000070233","article-title":"Cohort study of advanced IgA nephropathy. Efficacy and limitations of corticosteroids with tonsillectomy.","volume":"93","author":"Sato","year":"2003","journal-title":"Nephron Clin Pract"},{"key":"R5-14-20210211","first-page":"283","article-title":"Recurrent glomerulonephritis in the renal allograft: An update of selected areas.","volume":"3","author":"Couser","year":"2005","journal-title":"Exp Clin Transplant"},{"key":"R6-14-20210211","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1046\/j.1523-1755.2001.00006.x","article-title":"Kidney transplantation in patients with IgA mesangial glomerulonephritis.","volume":"60","author":"Ponticelli","year":"2001","journal-title":"Kidney Int"},{"key":"R7-14-20210211","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1399-3046.2004.00177.x","article-title":"Renal transplantation in patients with glomerulonephritis.","volume":"8","author":"Ponticelli","year":"2004","journal-title":"Pediatr Transplant"},{"key":"R8-14-20210211","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.transproceed.2005.09.172","article-title":"Recurrence of IgA nephropathy and HS purpura after kidney transplantation: Risk factor and graft survival.","volume":"37","author":"Soler","year":"2005","journal-title":"Transplant Proc"},{"key":"R9-14-20210211","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1081\/JDI-100104732","article-title":"Role of proteinuria reduction in the progression of IgA nephropathy.","volume":"23","author":"Locatelli","year":"2001","journal-title":"Ren Fail"},{"key":"R10-14-20210211","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1034\/j.1399-0012.1999.130406.x","article-title":"Clinical risk factors for recurrence of IgA nephropathy.","volume":"13","author":"Freese","year":"1999","journal-title":"Clin Transplant"},{"key":"R11-14-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000422388","article-title":"Follow up evaluation of the first patients with IgA nephropathy described in Necker Hospital.","volume":"104","author":"Chauveau","year":"1993","journal-title":"Contrib Nephrol"},{"key":"R12-14-20210211","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/ndt\/gfn161","article-title":"Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy.","volume":"23","author":"Lv","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R13-14-20210211","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/00365590701571514","article-title":"Mycophenolate mofetil treatment of crescentic Henoch-Schonlein nephritis with IgA depositions.","volume":"42","author":"Dede","year":"2008","journal-title":"Scand J Urol Nephrol"},{"key":"R14-14-20210211","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1440-1797.2006.00763.x","article-title":"Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.","volume":"12","author":"Sahin","year":"2007","journal-title":"Nephrology (Carton)"},{"key":"R15-14-20210211","first-page":"37","article-title":"Treatment of IgA nephropathy: Corticosteroids, tonsillectomy and mycophenolate mofetil [review].","volume":"157","author":"Kawamura","year":"2007","journal-title":"Contrib Nephrol"},{"key":"R16-14-20210211","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000168483","article-title":"Mycophenolate mofetil treatment for IgA nephropathy.","volume":"29","author":"Xu","year":"2009","journal-title":"Am J Nephrol"},{"key":"R17-14-20210211","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1046\/j.1523-1755.63.6s.2.x","article-title":"Incidence of latent IgA deposition in renal allograft donors in Japan.","volume":"63","author":"Suzuki","year":"2003","journal-title":"Kid Int"},{"key":"R18-14-20210211","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1523-1755.2004.00437.x","article-title":"Treatment of primary IgA nephropathy.","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"Kidney Int"},{"key":"R19-14-20210211","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1291\/hypres.29.15","article-title":"Impact of hypertension and hypertension related vascular lesions in IgA nephropathy.","volume":"29","author":"Ikee","year":"2006","journal-title":"Hypertens Res"},{"key":"R20-14-20210211","first-page":"381","article-title":"Clearance kinetics and fate of macromolecules IgA in patients with IgA nephropathy.","volume":"61","author":"Rifai","year":"1989","journal-title":"Lab Invest"},{"key":"R21-14-20210211","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0272-6386(88)80027-1","article-title":"Recurrence of IgA nephropathy in renal allografts.","volume":"12","author":"Berger","year":"1988","journal-title":"Am J Kidney Dis"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e3181b75374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:05:56Z","timestamp":1786039556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200910150-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,15]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181b75374","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10,15]]}}}